Publications by authors named "Alessandra Curioni-Fontecedro"

Claim this Profile
C
CD26 as a potential therapeutic target for lung adenocarcinoma.
Wolfgang Jungraithmayr, Birte Ohm, Martina Haberecker, Alessandra Curioni-Fontecedro, Florian Janker

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to immunotherapy in solid tumors.
Perrine Verdys, Astrid Z Johansen, Anurag Gupta, Mario Presti, Edoardo Dionisio, Alessandra Curioni-Fontecedro

Trends Mol Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, Edoardo Garbo, David J Pinato, Alessandra Curioni-Fontecedro

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of sotorasib clinical efficacy in KRAS-mutated non-small-cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, David S Hong, Herve Lena

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural mesothelioma.
Dean A Fennell, Yoshitaka Sekido, Paul Baas, Aliya N Husain, Alessandra Curioni-Fontecedro

Nat Rev Dis Primers· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial.
Matthias Guckenberger, Isabelle Opitz, Tereza Dellaporta, Alessandra Curioni-Fontecedro, Thomas Frauenfelder

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment-A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01, 16/08, and 16/14: A Brief Report.
Sabine Raimann, Sämi Schär, Stefanie Hayoz, Matthias Guckenberger, Tobias Finazzi, Alessandra Curioni-Fontecedro

JTO Clin Res Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato, Alessandra Curioni-Fontecedro

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project.
Martina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, Steven G Gray, Kristiaan Nackaerts, Alessandra Curioni-Fontecedro

JCO Precis Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC.
Maximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, Enric Carcereny, Christophe Dooms, Alessandra Curioni-Fontecedro

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma.
Federica Grosso, Luigi Cerbone, Alessandra Curioni-Fontecedro

Lancet Respir Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases.
Raphael S Werner, Markus Rechsteiner, Holger Moch, Alessandra Curioni-Fontecedro, Michael Weller

Eur J Cardiothorac Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-induction treatment for locally advanced non-small cell lung cancer: a case report of pathological complete response.
Raphael S Werner, Olivia Lauk, Georg Tscherry, Alessandra Curioni-Fontecedro, Sylvia Höller

J Cardiothorac Surg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer in Switzerland.
Raphael Sven Werner, Alessandra Curioni-Fontecedro, Laetitia A Mauti, Alfredo Addeo, Solange Peters

J Thorac Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.
Krisztian Homicsko, Panagiota Zygoura, Maxim Norkin, Stephanie Tissot, Nicholas Shakarishvili, Alessandra Curioni-Fontecedro

J Immunother Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma.
Antonio G Gennari, Alexia Rossi, Thomas Sartoretti, Alexander Maurer, Stephan Skawran, Alessandra Curioni-Fontecedro

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
Isabelle Opitz, Andrea Bille, Urania Dafni, Kristiaan Nackaerts, Luca Ampollini, Alessandra Curioni-Fontecedro

J Thorac Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype.
Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, Sandra N Freiberger, Susanne Kreutzer, Alessandra Curioni-Fontecedro

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated F18-FDG PET/CT image quality assessment using deep neural networks on a latest 6-ring digital detector system.
Moritz Schwyzer, Stephan Skawran, Antonio G Gennari, Stephan L Waelti, Joan Elias Walter, Alessandra Curioni-Fontecedro

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing.
Alexander Laure, Angelica Rigutto, Michaela B Kirschner, Lennart Opitz, Linda Grob, Alessandra Curioni-Fontecedro

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort.
Eva Grundmann, Alessandra Curioni-Fontecedro, Emanuel Christ, Alexander R Siebenhüner

BMC Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Neal E Ready, Clarisse Audigier-Valette, Jonathan W Goldman, Enriqueta Felip, Tudor-Eliade Ciuleanu

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET.
Stephan Skawran, Helen Schiesser, Alexander Maurer, Thomas Sartoretti, Manuel Dittli, Alessandra Curioni-Fontecedro

Vaccine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene.
Alessa Fischer, Lorenz Bankel, Stefanie Hiltbrunner, Markus Rechsteiner, Jan H Rüschoff, Alessandra Curioni-Fontecedro

Target Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of pleural and peritoneal mesothelioma tumours.
Stefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, Martin Zoche, Emanuela Felley-Bosco, Alessandra Curioni-Fontecedro

Br J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis